These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25492481)

  • 1. Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2.
    Zhuang M; Shi Q; Zhang X; Ding Y; Shan L; Shan X; Qian J; Zhou X; Huang Z; Zhu W; Ding Y; Cheng W; Liu P; Shu Y
    Tumour Biol; 2015 Apr; 36(4):2737-45. PubMed ID: 25492481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2.
    Wang T; Ge G; Ding Y; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
    Chin Med J (Engl); 2014; 127(12):2357-62. PubMed ID: 24931256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.
    Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P
    Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
    Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
    Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET.
    Zhang Z; Kong Y; Yang W; Ma F; Zhang Y; Ji S; Ma EM; Liu H; Chen Y; Hua Y
    Oncol Rep; 2016 Oct; 36(4):2391-7. PubMed ID: 27513895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
    Jiang T; Dong P; Li L; Ma X; Xu P; Zhu H; Wang Y; Yang B; Liu K; Liu J; Xue J; Lv R; Su P; Kong G; Chang Y; Zhao C; Wang L
    Oncol Rep; 2017 Jul; 38(1):151-158. PubMed ID: 28534959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines.
    Zhu W; Shan X; Wang T; Shu Y; Liu P
    Int J Cancer; 2010 Dec; 127(11):2520-9. PubMed ID: 20162574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
    Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.
    Zhu W; Zhu D; Lu S; Wang T; Wang J; Jiang B; Shu Y; Liu P
    Med Oncol; 2012 Mar; 29(1):384-91. PubMed ID: 21258880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-206 facilitates gastric cancer cell apoptosis and suppresses cisplatin resistance by targeting MAPK2 signaling pathway.
    Chen Z; Gao YJ; Hou RZ; Ding DY; Song DF; Wang DY; Feng Y
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):171-180. PubMed ID: 30657558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
    Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
    Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB.
    Han X; Zhang JJ; Han ZQ; Zhang HB; Wang ZA
    Cancer Gene Ther; 2018 Dec; 25(11-12):300-308. PubMed ID: 30237418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells.
    Hu J; Fang Y; Cao Y; Qin R; Chen Q
    Dig Dis Sci; 2014 Feb; 59(2):336-45. PubMed ID: 24248414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine modulates cisplatin sensitivity of human gastric cancer cells by upregulation of miR-203.
    You HY; Xie XM; Zhang WJ; Zhu HL; Jiang FZ
    In Vitro Cell Dev Biol Anim; 2016 Sep; 52(8):857-63. PubMed ID: 27142767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-187 influences cisplatin-resistance of gastric cancer cells through regulating the TGF-β/Smad signaling pathway.
    Zhu QL; Li Z; Lv CM; Wang W
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9907-9914. PubMed ID: 31799659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1.
    Zhang Y; Qu X; Li C; Fan Y; Che X; Wang X; Cai Y; Hu X; Liu Y
    Tumour Biol; 2015 Apr; 36(4):2277-85. PubMed ID: 25407491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD.
    Zhu M; Zhou X; Du Y; Huang Z; Zhu J; Xu J; Cheng G; Shu Y; Liu P; Zhu W; Wang T
    Mol Med Rep; 2016 Aug; 14(2):1742-50. PubMed ID: 27357419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR‑138‑5p modulates the expression of excision repair cross‑complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin.
    Ning J; Jiao Y; Xie X; Deng X; Zhang Y; Yang Y; Zhao C; Wang H; Gu K
    Oncol Rep; 2019 Feb; 41(2):1131-1139. PubMed ID: 30535472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a.
    Li Y; Lv S; Ning H; Li K; Zhou X; Xv H; Wen H
    Biomed Pharmacother; 2018 Dec; 108():1775-1782. PubMed ID: 30372881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.